EVMN
Evommune, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
No thesis.
Fund move
Fund move
Evommune, Inc.
6.72
−0.09 · −1.37%
post 6.72 0.00%
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | EQT Fund Management S.a r.l.EQT Fund Management S.a r.l. | $70.3M | 14.83% | +7.28% | |
| 2 | RA Capital ManagementRA Capital Management | $46.4M | 9.80% | 0.00% | |
| 3 | T. Rowe Price AssociatesT. Rowe Price | $25.8M | 5.44% | +73.45% | |
| 4 | Pivotal bioVenture Partners Investment AdvisorPivotal bioVenture Partners Investment Advisor | $25.6M | 5.40% | 0.00% | |
| 5 | JPMorgan ChaseJPMorgan Chase | $20.6M | 4.36% | new | |
| 6 | RTW InvestmentsRTW | $20.0M | 4.21% | 0.00% | |
| 7 | Nan Fung Group HoldingsNan Fung | $19.2M | 4.04% | 0.00% | |
| 8 | Point72 Asset ManagementPoint72 | $19.1M | 4.02% | +3823.36% | |
| 9 | Andera PartnersAndera Partners | $18.5M | 3.90% | −26.64% | |
| 10 | Eventide Asset ManagementEventide | $16.1M | 3.39% | 0.00% | |
| 11 | Vestal Point CapitalVestal Point Capital | $13.3M | 2.80% | new | |
| 12 | Jupiter TopcoJupiter Topco | $11.9M | 2.51% | — | |
| 13 | BlackRockBlackRockindex-like | $11.8M | 2.49% | +31.62% | |
| 14 | Vanguard Capital ManagementVanguardindex-like | $11.7M | 2.47% | +93.80% | |
| 15 | Baker Bros. AdvisorsBaker Bros. | $11.3M | 2.38% | 0.00% | |
| 16 | Defilade Capital ManagementDefilade | $10.5M | 2.22% | +16.88% | |
| 17 | American Century CompaniesAmerican Century Companies | $10.0M | 2.12% | +53.17% | |
| 18 | Alyeska Investment GroupAlyeska Investment | $9.4M | 1.98% | −3.02% | |
| 19 | Balyasny Asset ManagementBalyasny | $8.3M | 1.76% | new | |
| 20 | Affinity Asset AdvisorsAffinity Asset | $6.6M | 1.40% | new | |
| 21 | Velan Capital Investment ManagementVelan Capital | $6.0M | 1.27% | +1.12% | |
| 22 | UBS GroupUBS | $5.5M | 1.16% | +38.60% | |
| 23 | Federated InvestorsFederated Investors | $4.3M | 0.91% | 0.00% | |
| 24 | Great Point PartnersGreat Point Partners | $4.3M | 0.91% | 0.00% | |
| 25 | Freestone Grove PartnersFreestone Grove Partners | $4.1M | 0.86% | −9.18% |
107 managers report $473.8M of Evommune on form 13F for the quarter ended Jun 30 '26. 19 of them hold 80% of it; EQT Fund Management S.a r.l. is largest at 14.83%.
No implied move.
No implied move.
Expected move
No implied move.